B3GALT5 and malignant colon neoplasm: Analyses of the association between the expression of B3GALT5-AS1 and clinicopathologic features of colon cancers displayed that lower B3GALT5-AS1 expression is correlated with larger tumor size, distant metastasis, and advanced AJCC stages (Table 1).